Patient-reported outcomes in the RELIGHT clinical trial of ranibizumab in diabetic macular oedema.

Saved in:
Bibliographic Details
Title: Patient-reported outcomes in the RELIGHT clinical trial of ranibizumab in diabetic macular oedema.
Authors: Chakravarthy U; Departmentof Ophthalmology, Queens University, Belfast, UK., Pearce I; St Paul's Eye Unit, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK., Banerjee S; University Hospital of Wales, Cardiff, UK., Burton BJL; Departmentof Ophthalmology, James Paget University Hospital, Great Yarmouth, UK., Downey L; Department of Ophthalmology, Hull Royal Infirmary, Hull, UK., Gale R; Departmentof Ophthalmology, The York Hospital UK, York, UK., Patel J; Essex County Hospital, Colchester, UK., Patra S; Whipps Cross University Hospital, London, UK., Sivaprasad S; NIHR Moorfields Biomedical Research Centre, London, UK., Stevenson M; Medical Education, Queens University of Belfast, Belfast, UK., Lupton S; Departmentof Ophthalmology, Novartis Pharma UK, Frimley, UK.
Source: BMJ open ophthalmology [BMJ Open Ophthalmol] 2019 Apr 30; Vol. 4 (1), pp. e000226. Date of Electronic Publication: 2019 Apr 30 (Print Publication: 2019).
Publication Type: Journal Article
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101714806 Publication Model: eCollection Cited Medium: Internet ISSN: 2397-3269 (Electronic) Linking ISSN: 23973269 NLM ISO Abbreviation: BMJ Open Ophthalmol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2397-3269
DOI:10.1136/bmjophth-2018-000226